All stock lists
BioNexus Gene Lab Corp (NASDAQ:BGLC)
Malaysia · Delayed Price · Currency is USD
Basic Materials · Specialty Chemicals
1.19+0.00 (+0.00%)
Market cap
$3.49M
Website
Insider Score
––Not scored
BGLC Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BGLC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 76.16 K | 22.84 K | 483.76 K | 2.54 M | 2.26 M | — |
| Revenue Growth (YoY) | -96.63 % | — | — | — | — | — |
| Cost of Revenue | 63.17 K | 23.63 K | 487.74 K | 2.17 M | 1.89 M | — |
| Gross Profit | 12.98 K | -790.00 | -3.98 K | 377.69 K | 368.02 K | — |
| SG&A Expense | 334.55 K | 380.40 K | 1.01 M | 997.26 K | 1.13 M | — |
| R&D Expense | 13.67 K | 14.49 K | 11.10 K | 14.88 K | 12.56 K | — |
| Operating Expenses | 325.00 K | 570.64 K | 1.03 M | 1.19 M | 1.07 M | — |
| Operating Income | -312.02 K | -571.43 K | -1.03 M | -810.27 K | -699.99 K | — |
| Pretax Income | -286.45 K | -543.58 K | -1.04 M | -708.99 K | -616.17 K | — |
| Tax Provision | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -286.45 K | -543.58 K | -1.04 M | -708.99 K | -616.17 K | — |
| EPS (Basic) | -0.12 | -0.23 | — | -0.40 | -0.34 | -0.35 |
| EPS (Diluted) | -0.12 | -0.23 | — | -0.40 | -0.34 | -0.35 |
| Shares Outstanding | 2.42 M | 2.42 M | — | 1.80 M | 1.80 M | 1.80 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.